InvestorsHub Logo

runninggirl2016

11/06/16 8:28 AM

#163234 RE: georgejjl #163232

or the thought of getting a another dose every 3 months via injection for the rest of your life.

stevo99

11/06/16 9:43 AM

#163240 RE: georgejjl #163232

Sounds like Taltz has some nasty side effects:

For Healthcare Professionals
Applies to ixekizumab: subcutaneous solution

Dermatologic
Common (1% to 10%): Urticaria
Uncommon (0.1% to 1%): Angioedema[Ref]

Gastrointestinal
Common (1% to 10%): Nausea
Uncommon (0.1% to 1%): Oral candidiasis, inflammatory bowel disease[Ref]

Hematologic
Very common (10% or more): Neutropenia (11%)
Common (1% to 10%): Thrombocytopenia[Ref]

Immunologic
Very common (10% or more): Infections (26%), immunogenicity (22%)
Common (1% to 10%): Tinea infections, influenza
Uncommon (0.1% to 1%): Serious infections[Ref]

Local
Very common (10% or more): Injection site reactions (17%), erythema, pain[Ref]

Ocular
Common (1% to 10%): Conjunctivitis[Ref]

Respiratory
Very common (10% or more): Upper respiratory tract infections (including nasopharyngitis and rhinovirus infection) (14%)
Uncommon (0.1% to 1%): Rhinitis[Ref]

References
1. "Product Information. Taltz Autoinjector (ixekizumab)." Eli Lilly and Company, Indianapolis, IN.